Tony da Roma
10+ Posts
There are reports of possible Emergency Use Authorization or EUA by the FDA of one or more vaccines by early November.
The first groups offered vaccines would be health care workers and vulnerable groups -- elderly or those with comorbidities.
Then the expectation is that in the first quarter or half of 2021, vaccines would start to be rolled out to a wider population.
We've seen how stringent the EU has been with entry requirements for tourism this past summer. For instance, no Americans.
If they raised an "immunity passport" requirement, some documentation to show that you have been vaccinated for covid, would you get vaccinated in early 2021 in order to be able to travel internationally in 2021?
For context, vaccines typically take years to develop. For instance, Sanofi took almost 20 years to develop a vaccine for Dengue Fever and started rolling it out in the Philippines a few years ago. After a year of vaccinating almost 1 million youth there, it was discovered that the vaccine could have adverse effects including the deaths of several hundred children for those who had never had Dengue Fever before vaccination.
Sanofi had to change the requirement so that only those who previously had Dengue Fever could get the vaccine, which would prevent more severe reinfections but only for those previously exposed to the virus.
After that change, the EU and then the US FDA gave formal approvals.
The first groups offered vaccines would be health care workers and vulnerable groups -- elderly or those with comorbidities.
Then the expectation is that in the first quarter or half of 2021, vaccines would start to be rolled out to a wider population.
We've seen how stringent the EU has been with entry requirements for tourism this past summer. For instance, no Americans.
If they raised an "immunity passport" requirement, some documentation to show that you have been vaccinated for covid, would you get vaccinated in early 2021 in order to be able to travel internationally in 2021?
For context, vaccines typically take years to develop. For instance, Sanofi took almost 20 years to develop a vaccine for Dengue Fever and started rolling it out in the Philippines a few years ago. After a year of vaccinating almost 1 million youth there, it was discovered that the vaccine could have adverse effects including the deaths of several hundred children for those who had never had Dengue Fever before vaccination.
Sanofi had to change the requirement so that only those who previously had Dengue Fever could get the vaccine, which would prevent more severe reinfections but only for those previously exposed to the virus.
After that change, the EU and then the US FDA gave formal approvals.